These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Direct and indirect pathogenicity of Branhamella catarrhalis. Brook I Drugs; 1986; 31 Suppl 3():97-102. PubMed ID: 3488202 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905 [TBL] [Abstract][Full Text] [Related]
6. The increasing importance of Branhamella catarrhalis in respiratory infections. Van Hare GF; Shurin PA Pediatr Infect Dis J; 1987 Jan; 6(1):92-4. PubMed ID: 3547295 [No Abstract] [Full Text] [Related]
7. Bronchopulmonary infection due to Branhamella catarrhalis. McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451 [TBL] [Abstract][Full Text] [Related]
8. Otitis media and sinusitis in children. Role of Branhamella catarrhalis. Bluestone CD Drugs; 1986; 31 Suppl 3():132-41. PubMed ID: 3732081 [TBL] [Abstract][Full Text] [Related]
9. [Branhamella catarrhalis infection]. Zheng XT; Cao YP Zhonghua Yi Xue Za Zhi; 1988 Jan; 68(1):52-4. PubMed ID: 3133094 [No Abstract] [Full Text] [Related]